Quotes 5-day view Delayed Nasdaq
1 719 071
1 135 249
Estimated financial data (e) (USD)
Net income 2022
Net cash position 2022
P/E ratio 2022
Net income 2023
Net Debt 2023
P/E ratio 2023
EV / Sales 2022
EV / Sales 2023
Nbr of Employees
Gritstone bio, Inc. is a biotechnology company. The Company discover, develop, manufacture and deliver next generation cancer and infectious disease immunotherapy candidates by vaccine vectors, self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage development are GRANITE, individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared...
Ratings of Gritstone bio, Inc.
All news about GRITSTONE BIO, INC.
08/04 GRITSTONE BIO : Reports Second Quarter 2022 Financial Results and Provides Business Update..
08/04 GRITSTONE BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
08/04 Earnings Flash (GRTS) GRITSTONE BIO Reports Q2 Revenue $5.5M
08/04 TRANSCRIPT : Gritstone bio, Inc., Q2 2022 Earnings Call, Aug 04, 2022
08/04 Gritstone Reports Second Quarter 2022 Financial Results and Provides Business Update
08/04 Gritstone bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ende..
07/26 Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/22 GRITSTONE BIO, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Fin..
07/21 Gritstone to Report Second Quarter 2022 Financial Results and Provide Corporate Update ..
07/21 Gritstone Establishes Credit Facility for Up to $80 Million with Hercules Capital and S..
07/21 Gritstone Bio, Inc. Enters into an $80 Million Credit Facility with Hercules Capital, I..
07/05 Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/24 GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell Small Cap Comp Value Index
06/24 GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 3000E Value Index
06/24 GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 2500 Value Index
News in other languages on GRITSTONE BIO, INC.
Analyst Recommendations on GRITSTONE BIO, INC.
AstraZeneca : invests in Imperial's self-amplifying RNA technology with eye on future drugs
Chart GRITSTONE BIO, INC.
Technical analysis trends GRITSTONE BIO, INC.
Short Term Mid-Term Long Term Trends Bullish Neutral Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target